Mn-based degradable MOF nano-reactor as well as preparation method and application thereof
A nanoreactor and MOF technology, applied in the field of biomedicine, can solve problems such as large differences in physical and chemical properties and mechanism of action, and achieve the effect of overcoming tumor penetration and cell uptake barriers, overcoming blood circulation barriers, and inhibiting tumor metastasis and recurrence
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0051] Embodiment 1 reactor and preparation method thereof
[0052] A Mn-based degradable MOF nanoreactor controlled release system PCP-Mn-DTA@GOx@1-MT, which uses Mn-based ROS-responsive degradable MOF nanoparticles Mn-DTA as the core and functionalized grafting on its surface pH-responsive PEG-CDM-PEI shell, co-loaded with GOx and 1-MT, prepared a controlled release system.
[0053] The preparation process of the Mn-based degradable MOF nanoreactor controlled release system PCP-Mn-DTA@GOx@1-MT includes the following steps:
[0054] (1) Preparation of core Mn-based MOF nanoparticles Mn-DTA:
[0055] 11) Synthesis of ROS-responsive organic ligand 5,5-dimethyl-4,6-dithioazelaic acid (DTA):
[0056] Weigh 4.9mmol 3-mercaptopropionic acid (MPA) and dissolve it in 9.82mmol acetone solution, and stir continuously at room temperature for 8h. Then, the above mixed system was placed in an ice bath (ice-water mixture) overnight to make it crystallize. Filter to collect crystals. S...
experiment example 1
[0073] The product that each step of embodiment 1 obtains is through XRD, TEM, BET, 1 H NMR, DLS and Zeta potential analyzer, GPC, FTIR and other modern nano-testing and analysis techniques have systematically studied its morphology, composition and chemical bonds, and the results are as follows:
[0074] The present invention has analyzed the crystal structure of the Mn-DTA that embodiment obtains by X-ray diffraction, and the result is as follows figure 1 As shown in A, the XRD pattern of Mn-DTA presents strong diffraction peaks at 100°, 002°, 101°, 102°, 110°, 103° and 112°, which are consistent with the crystal structure of MnS compound. Among them, Mn-DTA also exhibited relatively sharp diffraction peaks, indicating that Mn-DTA single crystals have good crystallinity. In addition, the CCDC database calculation results show that Mn 2+ In fact, it coordinates with 3 DTA ligands to form a regular hexagonal prism structure (such as figure 1 As shown in Figure B-D), the thr...
experiment example 2
[0081] pH / ROS-responsive size reduction / charge inversion and drug release properties of Mn-based degradable MOF nanoreactor controlled release system.
[0082] The present invention utilizes H 2 o 2 To simulate the tumor microenvironment ROS, the characteristics of pH-responsive size reduction & charge reversal and ROS-responsive drug release of the system were tested. The specific results are as follows:
[0083] 1) PCP-Mn-DTA@GOx@1-MT controlled-release system pH-responsive size reduction & charge-reversal properties
[0084] The pH-responsive size reduction and charge inversion characteristics of the PCP-Mn-DTA@GOx@1-MT controlled release system were investigated by DLS and Zeta. Such as Figure 5As shown in Figure A, the size of PCP-Mn-DTA@GOx@1-MT is 97±4.5nm at pH 7.4 (simulating normal physiological conditions), while at pH 6.8 (simulating low acid stimulation of tumor microenvironment) After 4 hours of incubation at high temperature, the particle size decreased to...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap